CSI Market
Sign In | Register

Niagen Bioscience Inc (NAGE) Annual Balance Sheets

Annual · GAAP · USD millions
Access NAGE quarterly Balance Sheets →
This page allows investors to track Niagen Bioscience Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Accounts receivable9.74
Inventories20.42
Other Current Assets66.64
Total Current Assets96.81
Intangible Assets5.66
Prepaid Expense and Other Assets, Total1.31
Other Assets, Noncurrent2.63
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization1.32
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents64.79
Operating Lease Right Of Use Asset2.19
Total Assets106.41
Liabilities
Accounts Payable, Current AC10.80
Accrued Liabilities, Current AC7.72
Other Liabilities, Current1.40
Total Current Liabilities19.92
Total Long-term Debt0.00
Deferred Compensation Liability, Classified, Noncurrent LI5.47
Other liabilities, Noncurrent4.49
Operating Lease Liability Current1.00
Operating Lease Liability Noncurrent1.82
Finance Lease Liability Noncurrent-
Total Liabilities29.87
Stockholders' Equity
Translation Adjustment Functional To Reporting Currency Net Of Tax-0.01
Common Stock Value0.08
Additional Paid In Capital Common Stock240.99
Retained Earnings / Accumulated Deficit-164.53
Other Equity0.00
Common Stockholder's Equity76.53
Total Stockholder's Equity76.53
Liabilities & Stockholder's Equity106.41
4 historic quarters locked

Sign in to unlock the full Niagen Bioscience Inc balance sheet history.

Sign In Create Free Account

About Niagen Bioscience Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001386570-26-000013

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License